Gattefossé S.A.S., 36 chemin de Genas, BP 603, 69804 Saint-Priest, France.
Gattefossé S.A.S., 36 chemin de Genas, BP 603, 69804 Saint-Priest, France.
J Control Release. 2014 Aug 28;188:18-30. doi: 10.1016/j.jconrel.2014.06.004. Epub 2014 Jun 11.
Lipid excipients are attracting interest from drug developers due to their performance, ease of use, versatility and their potential to generate intellectual property through innovation in drug delivery particularly in the case of modifying drug release systems. Many articles have described the use of lipid excipients to develop matrix modified release dosage forms in a range of processing techniques, therefore a comprehensive review is timely to collect together and analyze key information. This review article focuses on the utility of lipid excipients in solid sustained drug delivery systems with emphasis on the efficiency and robustness of these systems with respect to: (i) the choice of the manufacturing process and impact on drug release, (ii) the fundamental drug release mechanisms, (iii) resistance of the drug formulation under physiological conditions and (iv) long-term stability. Understanding the functionality of these versatile excipients in formulation is elementary for the development of highly robust lipid-based sustained release medicines.
脂质辅料由于其性能、易用性、多功能性以及在药物传递方面通过创新产生知识产权的潜力(特别是在改变药物释放系统的情况下)而引起了药物开发者的兴趣。许多文章都描述了使用脂质辅料来开发一系列加工技术中的基质改性释放剂型,因此及时进行全面的综述以收集和分析关键信息是很有必要的。本文重点介绍了脂质辅料在固体持续药物传递系统中的应用,特别强调了这些系统在以下方面的效率和稳健性:(i)制造工艺的选择及其对药物释放的影响,(ii)基本的药物释放机制,(iii)药物制剂在生理条件下的抗药性,以及(iv)长期稳定性。了解这些多功能辅料在配方中的功能对于开发高度稳健的基于脂质的持续释放药物是基础。